470 related articles for article (PubMed ID: 21039318)
1. The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery.
Millotti G; Perera G; Vigl C; Pickl K; Sinner FM; Bernkop-Schnürch A
Drug Deliv; 2011 Apr; 18(3):190-7. PubMed ID: 21039318
[TBL] [Abstract][Full Text] [Related]
2. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
Yin L; Ding J; He C; Cui L; Tang C; Yin C
Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735
[TBL] [Abstract][Full Text] [Related]
3. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
[TBL] [Abstract][Full Text] [Related]
4. Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa.
Dünnhaupt S; Barthelmes J; Hombach J; Sakloetsakun D; Arkhipova V; Bernkop-Schnürch A
Int J Pharm; 2011 Apr; 408(1-2):191-9. PubMed ID: 21295123
[TBL] [Abstract][Full Text] [Related]
5. Chitosan-thioglycolic acid conjugate: an alternative carrier for oral nonviral gene delivery?
Martien R; Loretz B; Thaler M; Majzoob S; Bernkop-Schnürch A
J Biomed Mater Res A; 2007 Jul; 82(1):1-9. PubMed ID: 17265441
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
Rekha MR; Sharma CP
J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
[TBL] [Abstract][Full Text] [Related]
7. Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats.
Krauland AH; Guggi D; Bernkop-Schnürch A
J Control Release; 2004 Mar; 95(3):547-55. PubMed ID: 15023465
[TBL] [Abstract][Full Text] [Related]
8. Mucoadhesive hydrogel microparticles based on poly (methacrylic acid-vinyl pyrrolidone)-chitosan for oral drug delivery.
Sajeesh S; Sharma CP
Drug Deliv; 2011 May; 18(4):227-35. PubMed ID: 21067275
[TBL] [Abstract][Full Text] [Related]
9. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
Makhlof A; Tozuka Y; Takeuchi H
Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939
[TBL] [Abstract][Full Text] [Related]
10. In vivo evaluation of thiolated chitosan tablets for oral insulin delivery.
Millotti G; Laffleur F; Perera G; Vigl C; Pickl K; Sinner F; Bernkop-Schnürch A
J Pharm Sci; 2014 Oct; 103(10):3165-70. PubMed ID: 25139279
[TBL] [Abstract][Full Text] [Related]
11. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery.
Sajeesh S; Sharma CP
Int J Pharm; 2006 Nov; 325(1-2):147-54. PubMed ID: 16859846
[TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
Zhang Y; Wei W; Lv P; Wang L; Ma G
Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
[TBL] [Abstract][Full Text] [Related]
13. Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles.
Bravo-Osuna I; Vauthier C; Farabollini A; Palmieri GF; Ponchel G
Biomaterials; 2007 Apr; 28(13):2233-43. PubMed ID: 17261330
[TBL] [Abstract][Full Text] [Related]
14. Thiolated chitosans: development and in vitro evaluation of an oral tobramycin sulphate delivery system.
Hombach J; Hoyer H; Bernkop-Schnürch A
Eur J Pharm Sci; 2008 Jan; 33(1):1-8. PubMed ID: 17980561
[TBL] [Abstract][Full Text] [Related]
15. Thiomer nanoparticles: stabilization via covalent cross-linking.
Barthelmes J; Dünnhaupt S; Hombach J; Bernkop-Schnürch A
Drug Deliv; 2011 Nov; 18(8):613-9. PubMed ID: 22111974
[TBL] [Abstract][Full Text] [Related]
16. Bioadhesion and oral absorption of enoxaparin nanocomplexes.
Sun W; Mao S; Wang Y; Junyaprasert VB; Zhang T; Na L; Wang J
Int J Pharm; 2010 Feb; 386(1-2):275-81. PubMed ID: 19958824
[TBL] [Abstract][Full Text] [Related]
17. Elaboration and characterization of thiolated chitosan-coated acrylic nanoparticles.
Bravo-Osuna I; Schmitz T; Bernkop-Schnürch A; Vauthier C; Ponchel G
Int J Pharm; 2006 Jun; 316(1-2):170-5. PubMed ID: 16580797
[TBL] [Abstract][Full Text] [Related]
18. Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery.
Krauland AH; Guggi D; Bernkop-Schnürch A
Int J Pharm; 2006 Jan; 307(2):270-7. PubMed ID: 16300914
[TBL] [Abstract][Full Text] [Related]
19. Thiol functionalized polymethacrylic acid-based hydrogel microparticles for oral insulin delivery.
Sajeesh S; Vauthier C; Gueutin C; Ponchel G; Sharma CP
Acta Biomater; 2010 Aug; 6(8):3072-80. PubMed ID: 20144748
[TBL] [Abstract][Full Text] [Related]
20. Chitosan-graft-6-mercaptonicotinic acid: synthesis, characterization, and biocompatibility.
Millotti G; Samberger C; Fröhlich E; Bernkop-Schnürch A
Biomacromolecules; 2009 Nov; 10(11):3023-7. PubMed ID: 19821557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
